Home
About
- Overview
- Team
- Investors
Science
Pipeline
Partners
News & Events
Contact
Menu Menu

Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS

10 November 2022

Labiotech

https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/methode_sundaytimes.jpg 450 800 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2022-11-10 08:00:202026-08-14 14:47:07Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS

© NRG Therapeutics

Terms & Conditions
Privacy Policy

NRG announces £16m Series A for IND for Parkinson’s and ALS

NRG raises Series A funds for Parkinson’s and ALS therapy development